Ascendis Pharma (ASND1N) Q2 2025 Earnings Report
MX:ASND1N Q2 2025 EPS Results
- Actual EPS
- -MXN 17.20
- Consensus EPS
- -MXN 26.98
- Beat/Miss
- Beat by +MXN 9.78
- One Year Ago EPS
- -MXN 40.07
MX:ASND1N Q2 2025 Revenue Results
- Actual Revenue
- MXN 3.37B
- Expected Revenue
- MXN 3.02B
- Beat/Miss
- Beat by +MXN 345.66M
- YoY Revenue Growth
- +362.23%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/07/2025
- Time
- After Close
- Conference Call
- Thursday, August 7, 2025
MX:ASND1N Upcoming Earnings
Ascendis Pharma's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2025 Earnings Call Audio
MX:ASND1N Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:ASND1N Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | 16.49- | -20.98 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 31.4159.37 | -17.2 | 445.12% (+76.57) | |
| May 07, 2026 | 2026 (Q1) | 3.40204.54 | -33.15 | 717.09% (+237.69) | |
| Feb 11, 2026 | 2025 (Q4) | -1.68-11.54 | -13.43 | 14.06% (+1.89) | |
| Nov 12, 2025 | 2025 (Q3) | -5.12-20.98 | -36.08 | 41.86% (+15.10) | |
| Aug 07, 2025 | 2025 (Q2) | -26.98-17.20 | -40.07 | 57.07% (+22.87) | |
| May 01, 2025 | 2025 (Q1) | -30.78-33.15 | -48.25 | 31.30% (+15.10) | |
| Feb 12, 2025 | 2024 (Q4) | -20.64-13.43 | -32.31 | 58.44% (+18.88) | |
| Nov 14, 2024 | 2024 (Q3) | -32.83-36.08 | -56.43 | 36.06% (+20.35) | |
| Sep 03, 2024 | 2024 (Q2) | -30.59-40.07 | -45.31 | 11.57% (+5.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
